Drugs / Bivalent Subtype C gp120/MF59
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02968849 Comparator | Oct 2016 → Nov 2021 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bivalent Subtype C gp120/MF59 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02968849 ↗ |
| Route | Intramuscular | “delivered IM” NCT02968849 ↗ |